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One step in the right direction: improving syphilis screening 
and treatment in pregnant women in Africa
Substantial progress has been made in reproductive, 
maternal, neonatal, and child health globally, including in 
sub-Saharan Africa. Nevertheless, weaknesses in delivery 
platforms are a major barrier to further improvement 
of outcomes.1 Mother-to-child-transmission (MTCT) 
of syphilis is a public health concern worldwide.2 The 
prevention and management of syphilis is an essential 
element of antenatal care, because it can substantially 
reduce adverse pregnancy outcomes, including still-
births, perinatal deaths, and congenital syphilis.3 
However, implementation of effective programmes at 
antenatal clinics is falling short in most low-income and 
middle-income countries.4 Sub-Saharan Africa accounts 
for 63% of the global burden of maternal syphilis.2 
In this region in 2016–17, the median proportion of 
antenatal clinic attendees tested for syphilis was 56% 
(range 31–100), as reported by 31 (47%) of 66 countries 
monitoring this indicator; the proportion of antenatal 
clinic attendees who tested positive for syphilis, as 
reported by 30 countries, was 2·0% (range 0·1–7·6),5 but 
the proportion successfully treated is unknown.
Studies have shown that challenges to effective 
implementation include ensuring adequate supplies of 
commodities.6 In areas where no laboratory screening 
facilities can be accessed, rapid point-of-care (POC) tests 
have the potential to allow for treatment initiation at 
the same (preferably first) antenatal care visit.7 However, 
additional barriers, including health-care providers not 
having prescribing authority, not understanding same-
day screening and treatment, being unaware that one 
dose of penicillin is enough to prevent MTCT of syphilis, 
or simply being reluctant to implement policies, have 
also been highlighted.8
In this issue of the Lancet Global Health, Fernando 
Althabe and colleagues9 report on an 18-month cluster 
randomised trial in which 26 antenatal care urban clinics 
in Kinshasa, Democratic Republic of Congo (16 clinics) 
and Lusaka, Zambia (ten clinics) were assigned to receive 
either a health worker-focused behavioural interven-
tion plus supplies for syphilis testing and treatment 
(intervention group; 18 357 women) or supplies only 
(control group; 17 679 women). The primary outcomes 
were the proportion of pregnant women who had 
syphilis screening and the proportion of those testing 
positive who had treatment with benzathine penicillin 
at first antenatal care clinic visit.9
The behavioural intervention consisted of selection 
and training of peer facilitators within intervention 
clinics (health-care workers opinion leaders); individual 
antenatal care provider dis cussions (academic detailing); 
the use of reminders for testing and treatment; packaging 
of treatment kits; and monthly supportive super-
vision visits, on top of the provision of supplies (rapid 
treponemal tests, benzathine penicillin, and anaphylaxis 
treatment). The intervention achieved proportions of 
more than 95% for both screening and treatment, which 
is the standard set by WHO for elimination of MTCT of 
syphilis.10 In control clinics, the sole provision of supplies 
was sufficient to reach similar levels of screening (94%) 
but did not ensure treatment (43%; with a significant 
absolute difference of 57% [95% CI 13–99] between the 
intervention and control clinics; p=0·0028). The study 
findings highlight the importance of not only ensuring 
provision of supplies but also providing adequate training 
and supportive supervision to frontline health workers 
operating antenatal care services. It confirms the obvious: 
that screening for syphilis is only useful for reducing 
adverse birth outcomes if patients testing positive are 
then treated.11
The arrival of rapid POC treponemal tests has been 
heralded as a potential game changer over the previous 
generation of cumbersome semi-rapid non-treponemal 
tests. But their potential impact will depend on access of 
mothers to health centres, the availability of tests, and, 
notably, the motivation of providers to use them and 
their ability to provide treatment. These basic logistical 
conditions are often not met in hastily put together 
and poorly supervised programmes.12 Furthermore, 
the timing of treatment initiation during pregnancy is 
crucially important to avoid possible adverse outcomes 
of MTCT of syphilis, with highest efficacy if given before 
the 28th week of gestation.13 In settings with high 
HIV prevalence, HIV screening has often successfully 
been incorporated in routine antenatal care screening, 
resulting in high proportions of attendees screened 
for HIV.14 An increasingly promoted strategy is the use 
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of a dual rapid HIV and syphilis POC test (combining 
detection of the two infections on the same strip), which 
should enhance coverage of screening and management 
of both infections.15 It was therefore disappointing to 
note the low impact of the behavioural intervention 
on other antenatal care practices, such as screening 
for anaemia, proteinuria, and HIV. Although not an 
uncommon finding,12 this result calls for the design of 
better integrated or synergistic interventions to achieve 
an antenatal care package that would be truly beneficial 
to mothers and their babies.
Questions and challenges still arise from this study, from 
the generalisability of the findings to more rural clinics 
and those with lower patient turnover to the sustainability 
of an intensive essentially vertical-type supervision. The 
study did not provide data on, or attempt to measure, 
the quality of testing. The use of rapid POC diagnostics 
tests or any diagnostic test should comply with some 
basic form of quality control, such as those promoted by 
WHO.16 No information was available on the timing of 
detection and treatment of syphilis relative to gestational 
age. Furthermore, partner notification and treatment to 
prevent maternal reinfection or onward transmission was 
not described, although these are important components 
of the control of MTCT of syphilis.17 Hence, the real impact 
of the intervention in actually preventing congenital 
syphilis is not really known. However, this study is an 
essential step in the right direction.
Althabe and colleagues’ study9 is an important reminder 
that if we are to progress toward the elimination of MTCT 
of syphilis and HIV, access to, and quality of, maternal and 
neonate health services, including appropriate support of 
health workers, need to be assured. Notably, the rollout of 
evidence-based interventions in low-resource settings is 
only possible with the commitment of policy makers and 
the allocation of resources to secure the supply chain and 
human resource management.
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